A Neuropeptide Receptor Mutation That Lets People Sleep Less Without Memory Problems

A mutation in the neuropeptide S receptor allows some people (and engineered mice) to sleep less while remaining protected from the memory deficits that usually accompany sleep deprivation.

Xing, Lijuan et al.·Science translational medicine·2019·
RPEP-045642019RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

A missense mutation in the neuropeptide S receptor 1 (NPSR1) gene was identified in humans who naturally sleep less than average. When this mutation was engineered into mice, they also slept less despite having higher sleep pressure — and remarkably, they were resistant to the memory problems that normally accompany sleep deprivation. The mutant receptor showed increased sensitivity to neuropeptide S activation in vivo, suggesting the NPS/NPSR1 signaling pathway plays a critical role in regulating both sleep duration and the link between sleep and memory.

Key Numbers

How They Did This

The researchers identified the NPSR1 mutation through genetic analysis of families with natural short sleep phenotypes. They then created mice carrying the equivalent mutation and measured their sleep duration, sleep pressure, and memory performance using contextual memory tests after sleep deprivation. Receptor sensitivity was assessed by measuring responses to exogenous neuropeptide S administration in vivo.

Why This Research Matters

Most people who sleep less suffer cognitive consequences, but a small number of 'natural short sleepers' function perfectly well on fewer hours. This study identified a specific neuropeptide receptor mutation behind this trait, revealing a biological pathway that could one day be targeted to help people maintain cognitive function under sleep restriction — with potential applications for shift workers, military personnel, and people with sleep disorders.

The Bigger Picture

Neuropeptide S is part of a growing roster of brain peptides — alongside orexin/hypocretin, neuropeptide Y, and galanin — that regulate the sleep-wake cycle. This discovery is particularly significant because it links a single peptide receptor variant to both reduced sleep need and preserved cognitive function, challenging the assumption that less sleep always means worse brain performance. It opens a new avenue for understanding how peptide signaling protects brain function.

What This Study Doesn't Tell Us

The mutation was identified in a small number of human families, so its prevalence and effects across diverse populations are unknown. Mouse models may not fully recapitulate human sleep regulation. The study does not address long-term health consequences of reduced sleep in carriers of this mutation, and the mechanism by which the mutant receptor preserves memory consolidation despite less sleep is not fully explained.

Questions This Raises

  • ?Could drugs targeting the NPS/NPSR1 pathway help people maintain cognitive performance under sleep restriction?
  • ?Are carriers of this mutation protected from other consequences of short sleep, such as cardiovascular risk or immune dysfunction?
  • ?How does the mutant NPSR1 receptor preserve memory consolidation — does it enhance specific sleep stages or activate alternative consolidation pathways?

Trust & Context

Key Stat:
Sleep less, remember more Mice with the NPSR1 mutation slept less but were resistant to memory deficits from sleep deprivation
Evidence Grade:
This study combines human genetic discovery with a validated mouse model, published in the high-impact journal Science Translational Medicine. It provides strong mechanistic evidence but is based on a rare mutation found in a small number of families.
Study Age:
Published in 2019, this study remains highly cited and relevant as research into the neuropeptide S pathway and natural short sleep phenotypes continues to advance.
Original Title:
Mutant neuropeptide S receptor reduces sleep duration with preserved memory consolidation.
Published In:
Science translational medicine, 11(514) (2019)
Database ID:
RPEP-04564

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What is neuropeptide S and what does it do in the brain?

Neuropeptide S is a small signaling molecule in the brain that promotes wakefulness and arousal. It works by binding to the NPSR1 receptor on brain cells. This study found that a mutation making this receptor extra-sensitive to neuropeptide S allows some people to function well on less sleep.

Does this mean sleeping less is fine if you have the right genes?

Only for the very small number of people with specific genetic variants like this NPSR1 mutation. For most people, consistently sleeping less than 7 hours is associated with cognitive decline, cardiovascular problems, and other health risks. This study helps explain why a rare few are exceptions, not that short sleep is generally safe.

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-04564·https://rethinkpeptides.com/research/RPEP-04564

APA

Xing, Lijuan; Shi, Guangsen; Mostovoy, Yulia; Gentry, Nicholas W; Fan, Zenghua; McMahon, Thomas B; Kwok, Pui-Yan; Jones, Christopher R; Ptáček, Louis J; Fu, Ying-Hui. (2019). Mutant neuropeptide S receptor reduces sleep duration with preserved memory consolidation.. Science translational medicine, 11(514). https://doi.org/10.1126/scitranslmed.aax2014

MLA

Xing, Lijuan, et al. "Mutant neuropeptide S receptor reduces sleep duration with preserved memory consolidation.." Science translational medicine, 2019. https://doi.org/10.1126/scitranslmed.aax2014

RethinkPeptides

RethinkPeptides Research Database. "Mutant neuropeptide S receptor reduces sleep duration with p..." RPEP-04564. Retrieved from https://rethinkpeptides.com/research/xing-2019-mutant-neuropeptide-s-receptor

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.